Blue light cystoscopy beneficial for finding invasive bladder tumors
Analyses of data from a multi-institutional registry show that blue light cystoscopy using hexaminolevulinate HCl (Cysview) detects invasive bladder tumors that are missed by white light cystoscopy in an appreciable number of patients.
Get the data
ADVERTISEMENT
 
6-month progression is strong survival surrogate in mHSPC
Disease progression within 6 months was the strongest surrogate marker for overall survival in patients with metastatic hormone-sensitive prostate cancer treated with combination therapy in a retrospective analysis of the CHAARTED trial.
Learn more
 
Video: Surveillance for small renal masses appears safe at 10 years
Phillip M. Pierorazio, MD, discusses results from a study that showed that active surveillance for small renal masses was safe and noninferior to primary intervention at 10 years.
Watch the video